| Literature DB >> 30371039 |
Abstract
Mitochondrial disorders are increasingly recognised world-wide and represent a diagnostic and therapeutic challenge. This is due to the peculiarities of mitochondrial genetics and the extreme genotypic and phenotypic heterogeneity of these disorders. Traditional time-consuming and expensive diagnostic steps are increasingly replaced by first-line genetic approaches. Despite recent advances in the treatment and prevention of mitochondrial disorders, therapeutic approaches are still limited mainly to non-invasive or invasive symptomatic measures. Copyright© of YS Medical Media ltd.Entities:
Keywords: Diagnosis; Mitochondrial; Multiorgan; Multisystem; Nuclear DNA; Treatment; mtDNA
Mesh:
Substances:
Year: 2018 PMID: 30371039 DOI: 10.17458/per.vol16.2018.f.mitochondrialdisorders
Source DB: PubMed Journal: Pediatr Endocrinol Rev ISSN: 1565-4753